Fusen Pharmaceutical Company Limited
HKEX:1652.HK
Overview | Financials
Company Name | Fusen Pharmaceutical Company Limited |
Symbol | 1652.HK |
Currency | HKD |
Price | 1 |
Market Cap | 745,035,000 |
Dividend Yield | 0% |
52-week-range | 0.76 - 1.6 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Zhiming Cao |
Website | https://www.fusenyy.com |
An error occurred while fetching data.
About Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD